OR13A1
Olfactory receptor 13A1
Also known as: O13A1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NGR1
- Gene
- OR13A1
- Ensembl
- ENSG00000256574
- Chromosome
- 10
- Canonical length
- 328 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins
OverviewNCBI Gene
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
328 residues, UniProt reviewed canonical sequence.
>Q8NGR1|OR13A1
1 MKLWMESHLI VPETRPSPRM MSNQTLVTEF ILQGFSEHPE YRVFLFSCFL FLYSGALTGN
61 VLITLAITFN PGLHAPMYFF LLNLATMDII CTSSIMPKAL ASLVSEESSI SYGGCMAQLY
121 FLTWAASSEL LLLTVMAYDR YAAICHPLHY SSMMSKVFCS GLATAVWLLC AVNTAIHTGL
181 MLRLDFCGPN VIIHFFCEVP PLLLLSCSST YVNGVMIVLA DAFYGIVNFL MTIASYGFIV
241 SSILKVKTAW GRQKAFSTCS SHLTVVCMYY TAVFYAYISP VSGYSAGKSK LAGLLYTVLS
301 PTLNPLIYTL RNKEVKAALR KLFPFFRNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OR13A1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 1 nTPM
Expression across tissuesHPA
Tissue
- urinary bladder: 1 nTPM
- spleen: 0.7 nTPM
- cerebellum: 0.6 nTPM
- thymus: 0.6 nTPM
- small intestine: 0.5 nTPM
- esophagus: 0.4 nTPM
Single-cell type
- papillary tip epithelial cells: 1.6 nCPM
- oligodendrocyte progenitor cells: 0.5 nCPM
- brain excitatory neurons: 0.4 nCPM
- brain inhibitory neurons: 0.3 nCPM
- microglia: 0.3 nCPM
- oligodendrocytes: 0.3 nCPM
Immune cell
- memory B-cell: 0.4 nTPM
- naive CD8 T-cell: 0.1 nTPM
- non-classical monocyte: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- cerebellum: 0.2 nTPM
- cerebral cortex: 0.2 nTPM
- hypothalamus: 0.2 nTPM
- amygdala: 0.1 nTPM
- basal ganglia: 0.1 nTPM
- hippocampal formation: 0.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.43
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.1
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OR13A1 as an antibody target. Whether an autoantibody or antibody against OR13A1 could matter depends on whether native OR13A1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OR13A1 is annotated at the cell surface, where native OR13A1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label OR13A1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...